Melio’s revolutionary technology advances pathogen profiling by integrating proprietary assay, state-of-the-art microfluidics and cutting-edge machine-learning techniques.
Melio is leading the next generation of DNA melting technology, identifying pathogens by capturing their unique DNA melt curves, and classifying them using advanced artificial intelligence.
Through complex machine learning algorithms, these profiles are used to accurately identify pathogens from a new blood sample within a matter of hours — giving care providers dependable diagnostic capabilities rapidly.
Rapid Identification of New Pathogens
And because Melio’s solution is scalable — when new pathogens are discovered and recorded, their specific profiles can be transmitted ‘over the air’ for healthcare providers around the world.